MODIFICATION BY AZ-55, GUANETHIDINE AND BRETYLIUM OF RESPONSES OF ATRIA AND AORTIC STRIPS TO TRANSMURAL STIMULATION

MODIFICATION BY AZ-55, GUANETHIDINE AND BRETYLIUM OF RESPONSES OF ATRIA AND AORTIC STRIPS TO TRANSMURAL STIMULATION

A new antihypertensive drug (1), 1-cyclohexyl-3-guanidinoazetidine sulfate (AZ-55), structurally resembles guanethidine. It is widely known that guanethidine depresses peripheral adrenergic nerve function by preventing release of adrenergic nerve transmitters (reviewed by Boura and Green, 2). Bretyl...

Full description

Saved in:
Bibliographic Details
Published in:Japanese journal of pharmacology Vol. 22; no. 1; pp. 125 - 135
Main Authors: TODA, Noboru, USUI, Hachiro, SHIMAMOTO, Kiro
Format: Journal Article
Language:English
Published: The Japanese Pharmacological Society 1972
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A new antihypertensive drug (1), 1-cyclohexyl-3-guanidinoazetidine sulfate (AZ-55), structurally resembles guanethidine. It is widely known that guanethidine depresses peripheral adrenergic nerve function by preventing release of adrenergic nerve transmitters (reviewed by Boura and Green, 2). Bretylium also possesses the adrenergic neuron blocking action, but accumulated data point to the fact that bretylium and guanethidine fail to share all mechanisms of the blocking action (2). The present study was aimed to investigate the effects of AZ-55 on responses of S-A nodes of the heart and of aortic smooth muscles to transmural neural stimulation, tyramine and noradrenaline. Effects were then compared with those of guanethidine and bretylium.
ISSN:0021-5198
1347-3506
DOI:10.1254/jjp.22.125